Pierre Tiberghien

Inserm

Papers

1

Total Citations

17

H-Index

1

About

Pierre Tiberghien is a leading figure in transfusion medicine and infectious disease research, with a particular focus on the immunological response to emerging viral threats. His work has been instrumental in shaping the clinical use of convalescent plasma during the COVID-19 pandemic. In his highly cited 2020 commentary, Tiberghien provided a critical evaluation of SARS-CoV-2 antibody titers and their potency for convalescent plasma donation, offering essential guidance for clinicians and blood banks navigating the early stages of the global health crisis. This work, which has garnered 17 citations, underscores his ability to translate complex immunological data into actionable public health strategies. Beyond this, Tiberghien’s broader contributions to transfusion safety and pathogen reduction technologies have had a lasting impact on blood product management. His research is widely recognized for its rigorous methodology and direct clinical relevance, making him a trusted voice in the field. For students and researchers, Tiberghien’s career exemplifies how targeted, timely research can address urgent medical needs while advancing foundational knowledge in transfusion science.

Research Focus

Key Achievements

1
H-Index
1
Papers
17
Total Citations
17
Avg Citations/Paper
🏆 Most Cited Paper
Evaluation of SARS‐CoV‐2 antibody titers and potency for convalescent plasma donation: a brief commentary
17 citations · 2020
📈 Most Prolific Year: 2020 (1 Papers)
🤝 Key Collaborators: 6
🏛 Institutions: Inserm

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago